Unbiased drug selection for audit using distributed ledger technology
US11093552B2 · kind B2 · utility
Assignee
Inventor
Key dates
| Filing date | Apr 16, 2019 |
| Grant date | Aug 17, 2021 |
| Priority date | — |
| Expiry date | May 11, 2040 |
Classification
- Technology area (CPC H)Electricity
- CPC primaryH04L2209/88
- WIPO fieldDigital communication
- WIPO sectorElectrical engineering
Abstract
A computer-implemented method of auditing drug supply chain data gathered from a distributed ledger is disclosed. The method includes receiving a population of drug product records from the distributed ledger. The method includes receiving a first set of drug product criteria. The method includes determining a weighted probability for one or more drug product records of the population of drug product records. The method includes generating a randomized first subset of drug product records from the population of drug product records based on the weighted probability of the one or more drug product records. Other methods, systems, and the like for unbiased drug selection for audit are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.